Publication Registration: |
Wednesday, August 30, 2017 |
Goods and Services Information
|
Description:
|
(1) - Pharmaceutical preparations for the prevention and treatment of neurological diseases, namely multiple sclerosis, Alzheimer's, Huntington's disease and cerebral palsy; psychiatric diseases, namely mood disorders, anxiety disorders, cognitive disorders and schizophrenia and for the prevention and treatment of autoimmune diseases; and anti-inflammatory medications
(2) - Pharmaceutical preparations for the prevention and treatment of neurological diseases, namely multiple sclerosis, Alzheimer's, Huntington's disease and cerebral palsy; pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely mood disorders, anxiety disorders, cognitive disorders and schizophrenia, and for the prevention and treatment of immunologic diseases, namely, autoimmune diseases; and anti-inflammatory medications
(3) - Pharmaceutical preparations for the prevention and treatment of neurological diseases, namely multiple sclerosis, Alzheimer's, Huntington's disease and cerebral palsy; pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely mood disorders, anxiety disorders, cognitive disorders and schizophrenia, and for the prevention and treatment of immunologic diseases, namely, autoimmune diseases; and anti-inflammatory medications
(4) - Pharmaceutical preparations for the prevention and treatment of neurological diseases, namely multiple sclerosis, Alzheimer's, Huntington's disease and cerebral palsy; pharmaceutical preparations for the prevention and treatment of psychiatric diseases, namely mood disorders, anxiety disorders, cognitive disorders and schizophrenia, and for the prevention and treatment of immunologic diseases, namely, autoimmune diseases; and anti-inflammatory medications
|